SCHEMBL20547144

SCHEMBL20547144

CC(C)(C)OC(=O)N1CCc2c(-c3ccccc3F)nn(C(=O)OC(C)(C)C)c2CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.55
GRM5 P41594 3/20 0.42
GRM1 Q13255 3/20 0.42
PDK4 Q16654 1/20 0.40
P2RX3 P56373 1/20 0.40
PARP1 P09874 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
PTK2 Q05397 1/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
CSNK1D P48730 1/20 0.39
CSNK1E P49674 1/20 0.39
CKS1B P61024 1/20 0.39
SKP1 P63208 1/20 0.39
SKP2 Q13309 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547193 0.88 RORC (0.48) RORCGRM5GRM1PDK4PARP1
SCHEMBL20547294 0.87 RORC (0.55) RORCPDK4PARP1TNKS2PARP2
SCHEMBL20547247 0.84 CKS1B (0.51) RORCGRM5GRM1CKS1BSKP1
SCHEMBL20547249 0.81 RORC (0.50) RORCGRM5GRM1CSNK1DCSNK1E
SCHEMBL20547291 0.79 GPR119 (0.45) RORCGRM5CKS1BSKP1SKP2
SCHEMBL20547216 0.78 RORC (0.47) RORCGRM5JAK2CKS1BSKP1
SCHEMBL20547213 0.77 RORC (0.50) RORCGRM5JAK2SMN1; SMN2BRD4
SCHEMBL24417770 0.73 P2RX7 (0.52) RORCCKS1BSKP1SKP2GPR119
SCHEMBL16518226 0.73 PTGDR2 (0.53)
SCHEMBL3674036 0.72 CKS1B (0.52) GRM5GRM1SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A RORC 1569/4885GRM5 31/4885GRM1 147/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A RORC 1569/4885GRM5 31/4885GRM1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.